Venetoclax 100mgTablet
Anti-Cancer

Venetoclax 100mg

Venetoclax

First-in-class selective BCL-2 inhibitor that restores apoptosis in CLL cells by displacing pro-apoptotic BIM protein, providing highly effective targeted therapy for CLL/SLL including 17p-deleted disease. Indian generics from Natco and Cipla offer access to this breakthrough haematological agent for export.

Strengths

10mg / 50mg / 100mg

Packing

14 tablets/pack

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Venetoclax 10mg / 50mg / 100mg
Dosage Form
Tablet
Available Strengths
10mg / 50mg / 100mg
Packing
14 tablets/pack
Route of Administration
Oral, with a meal and water
Dosage
5-week ramp-up: 20mg, 50mg, 100mg, 200mg, 400mg weekly; then 400mg daily
Indications
CLL/SLL with or without 17p deletion, AML in combination with azacitidine or decitabine in unfit patients
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
36 months
Side Effects
Neutropenia, diarrhea, nausea, anemia, fatigue, thrombocytopenia, upper respiratory infection, tumor lysis syndrome
Precautions
Tumor lysis syndrome prevention protocol mandatory; gradual dose ramp-up required; monitor CBC; strong CYP3A inhibitors require dose reduction; avoid grapefruit

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Venetoclax 100mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote